186 related articles for article (PubMed ID: 17426933)
1. [Diagnostics, classification and prognostic criteria of acute myeloid leukemia].
Heilmeier B; Buske C; Spiekermann K; Bohlander S; Feuring-Buske M; Hiddemann W; Braess J
Med Klin (Munich); 2007 Apr; 102(4):296-308. PubMed ID: 17426933
[TBL] [Abstract][Full Text] [Related]
2. [Modern leukemia diagnosis in adults].
Heilmeier B; Spiekermann K; Bohlander S; Buske C; Feuring-Buske M; Schneider S; Hiddemann W; Braess J
Dtsch Med Wochenschr; 2009 Jun; 134(23):1222-6. PubMed ID: 19472094
[TBL] [Abstract][Full Text] [Related]
3. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetics of pediatric acute myeloid leukemia.
Manola KN
Eur J Haematol; 2009 Nov; 83(5):391-405. PubMed ID: 19563518
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
6. Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Childrens Cancer Group.
Barnard DR; Kalousek DK; Wiersma SR; Lange BJ; Benjamin DR; Arthur DC; Buckley JD; Kobrinsky N; Neudorf S; Sanders J; Miller LP; Shina DC; Hammond GD; Woods WG
Leukemia; 1996 Jan; 10(1):5-12. PubMed ID: 8558938
[TBL] [Abstract][Full Text] [Related]
7. [Classification of AML by morphologic, immunologic and cytogenetic criteria. Review with reference to subtypes in the AML-BFM-87 study].
Creutzig U; Ritter J; Ludwig WD; Harbott J; Löffler H; Schellong G
Klin Padiatr; 1993; 205(4):272-80. PubMed ID: 8377447
[TBL] [Abstract][Full Text] [Related]
8. Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemia.
Verhaak RG; Valk PJ
Cancer Treat Res; 2010; 145():67-83. PubMed ID: 20306246
[TBL] [Abstract][Full Text] [Related]
9. A modern classification of the acute non-lymphoblastic leukaemias.
Hayhoe FG
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():70-2. PubMed ID: 2653522
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of cytogenetics in acute myeloid leukemia.
Grimwade D; Mrózek K
Hematol Oncol Clin North Am; 2011 Dec; 25(6):1135-61, vii. PubMed ID: 22093581
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostics and therapy of acute myeloid leukemia].
Kern W; Haferlach T; Schoch C; Hiddemann W
Dtsch Med Wochenschr; 2002 Oct; 127(42):2208-13. PubMed ID: 12397550
[No Abstract] [Full Text] [Related]
12. [Pathobiology of acute myeloid leukemia].
Christ O; Feuring-Buske M; Hiddemann W; Buske C
Med Klin (Munich); 2007 Apr; 102(4):290-5. PubMed ID: 17426932
[TBL] [Abstract][Full Text] [Related]
13. Dominant and opportunistic leukemic clones: proposal for a pathogenesis-oriented classification in acute myeloid leukemia.
Cucuianu A
Med Hypotheses; 2005; 65(1):107-13. PubMed ID: 15893127
[TBL] [Abstract][Full Text] [Related]
14. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
15. Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse.
Wang ES; Sait SN; Gold D; Mashtare T; Starostik P; Ford LA; Wetzler M; Nowak NJ; Deeb G
Cancer Genet Cytogenet; 2010 Oct; 202(2):101-7. PubMed ID: 20875872
[TBL] [Abstract][Full Text] [Related]
16. Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia.
Ye J; Cao Q; Su X; Huang Q; Ma Z; Wang Z; Huang W; Chen Z; Chen S
Chin Med J (Engl); 1997 Feb; 110(2):90-5. PubMed ID: 9594276
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetics in the management of acute myeloid leukemia: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Luquet I; Bidet A; Cuccuini W; Lafage-Pochitaloff M; Mozziconacci MJ; Terré C
Ann Biol Clin (Paris); 2016 Oct; 74(5):535-546. PubMed ID: 27545007
[TBL] [Abstract][Full Text] [Related]
19. Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factors.
Stasi R; Venditti A; Del Poeta G; Aronica G; Dentamaro T; Cecconi M; Stipa E; Scimò MT; Masi M; Amadori S
Cancer; 1996 Jun; 77(12):2476-88. PubMed ID: 8640696
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.
Ghanem H; Tank N; Tabbara IA
Am J Hematol; 2012 Jan; 87(1):69-77. PubMed ID: 22072438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
